Meritage Portfolio Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.48M Sell
61,020
-14,783
-20% -$1.57M 0.41% 65
2025
Q1
$9.41M Buy
75,803
+9,529
+14% +$1.18M 0.62% 40
2024
Q4
$8.16M Sell
66,274
-14,333
-18% -$1.77M 0.51% 50
2024
Q3
$8.98M Sell
80,607
-771
-0.9% -$85.9K 0.55% 40
2024
Q2
$8.69M Sell
81,378
-1,159
-1% -$124K 0.55% 42
2024
Q1
$9.94M Sell
82,537
-2,502
-3% -$301K 0.63% 34
2023
Q4
$10.5M Buy
85,039
+4,727
+6% +$581K 0.69% 29
2023
Q3
$10.4M Buy
80,312
+2,331
+3% +$302K 0.77% 26
2023
Q2
$9.67M Sell
77,981
-7,289
-9% -$904K 0.68% 30
2023
Q1
$12.5M Buy
85,270
+34,987
+70% +$5.12M 0.93% 20
2022
Q4
$8.01M Buy
+50,283
New +$8.01M 0.63% 39
2018
Q3
Sell
-33,564
Closed -$5.78M 203
2018
Q2
$5.78M Sell
33,564
-248
-0.7% -$42.7K 0.56% 61
2018
Q1
$5.11M Buy
+33,812
New +$5.11M 0.49% 83
2016
Q4
Sell
-30,225
Closed -$3.67M 193
2016
Q3
$3.67M Sell
30,225
-23
-0.1% -$2.79K 0.4% 127
2016
Q2
$4.27M Buy
+30,248
New +$4.27M 0.48% 107